Roles of RORalpha in breast cancer development and progression
RORalpha 在乳腺癌发生和进展中的作用
基本信息
- 批准号:10440464
- 负责人:
- 金额:$ 22.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAgonistBiological AssayBiologyBreastBreast Cancer CellBreast Cancer ModelBreast Epithelial CellsCell PolarityCellular Metabolic ProcessChronicCoculture TechniquesComplexDevelopmentDown-RegulationEpithelial CellsGene ExpressionGene Expression ProfilingGenerationsGlutathione DisulfideGoalsHumanHydrogen PeroxideImmunocompetentInfiltrationInflammationKnockout MiceKnowledgeLeadLinkMalignant NeoplasmsMeasurementMediatingMetabolicMetforminMitochondriaModelingMolecularMusNADPNatureNeoplasm MetastasisNuclear Orphan ReceptorOxidation-ReductionPathway interactionsPositioning AttributeProductionReactive Oxygen SpeciesResearchRoleSchemeSourceStructureSuperoxidesSystemTP53 geneTestingTissue MicroarrayTissuesTumor Suppressor Proteinsbasebreast cancer progressioncancer cellcancer preventioncancer therapycytokinedruggable targethealingimprovedinhibitorinsightknock-downloss of functionmacrophagemalignant breast neoplasmmammarymetabolomicsmonocytemultidisciplinarynovelnovel strategiesstable isotopetranscriptometranslational potentialtumortumor microenvironmenttumor progressionwound
项目摘要
ABSTRACT
Tumor has been described as the wounds that do not heal. The two share some common features, such as
loss of polarized tissue structure and chronic inflammation. We showed that disruption of tissue polarity
induced macrophage infiltration. However, little is known of how disruption of epithelial cell polarity at early
stage of breast cancer development induces macrophage infiltration. We have identified the RAR-related
orphan nuclear receptor α (RORα) as a potent tumor suppressor by analyzing global gene expression profiles
in polarized and non-polarized mammary epithelial cells. Our recent findings show that RORα inhibits ROS
generation and macrophage infiltration in the syngeneic mouse mammary tumor model. These results suggest
that RORα is a potent suppressor of macrophage infiltration in mammary epithelial cells. We found that
knockdown of RORα significantly induced ROS production in mammary epithelial cells. Reactive oxygen
species (ROS) are the driver of cancer progression and critical regulator of the NF-κB pathway. Based on
these novel findings, the central hypothesis of our proposal is that downregulation of RORα in non-polarized
breast cancer cells increased ROS generation in mitochondria, thereby inducing NF-κB and macrophage
infiltration. We integrate high-throughput metabolic analysis, a novel 3D co-culture system, and global gene
expression profiling to delineate mechanisms by which RORα inhibits ROS production and macrophage
infiltration. The long-term goal of this proposal is to define the impact of the RORα/ROS axis in mediating
mammary epithelial cell-macrophage crosstalk and in regulating breast cancer progression. We have proposed
following specific aims to test the hypothesis: Aim 1. To elucidate the molecular mechanisms by which RORα
reduces ROS levels and NF-κB activity in polarized mammary epithelial cells; Aim 2. To determine how
reduced RORα expression in non-polarized breast cancer cells induces macrophage infiltration and M2
polarization; Aim 3. Define the impact of RORα in suppressing breast cancer formation and metastasis. The
proposed study is high impact for its inherent scientific importance and its translational potential. This study will
elucidate the molecular mechanism by which disruption of tissue polarity induces macrophage
infiltration/differentiation. Determining roles of RORα in reducing ROS generation and inhibiting NF-κB
activation may identify a novel strategy to inhibit breast cancer development and progression.
抽象的
肿瘤被描述为无法愈合的伤口。这两个共享一些共同的功能,例如
极化组织结构和慢性感染的丧失。我们表明组织极性的破坏
诱导的巨噬细胞浸润。但是,几乎不知道早期上皮细胞极性如何破坏
乳腺癌发育的阶段诱导巨噬细胞浸润。我们已经确定了与RAR相关的
孤儿核接收器α(RORα)通过分析的全球基因表达谱作为有效的肿瘤抑制器
在极化和非极化乳腺上皮细胞中。我们最近的发现表明RORα抑制ROS
合成小鼠乳腺肿瘤模型中的产生和巨噬细胞浸润。这些结果表明
该RORα是乳腺上皮细胞中巨噬细胞浸润的有效抑制剂。我们发现
RORα的敲低可显着诱导乳腺上皮细胞的ROS产生。活性氧
物种(ROS)是癌症进展的驱动力和NF-κB途径的关键调节剂。基于
这些新的发现,我们提议的中心假设是,非偏振的RORα下调
乳腺癌细胞增加了线粒体中ROS的产生,从而诱导NF-κB和巨噬细胞
浸润。我们整合了高通量代谢分析,一种新型的3D共培养系统和全球基因
表达分析到描述RORα抑制ROS产生和巨噬细胞的机制
浸润。该提案的长期目标是定义RORα/ROS轴的影响
乳腺上皮细胞巨噬细胞串扰和控制乳腺癌的进展。我们提出了
以下特定旨在检验假设的特定目的:目的1。阐明RORα的分子机制
降低了极化乳腺上皮细胞中的ROS水平和NF-κB活性;目标2。确定如何
降低了非极化乳腺癌细胞中的RORα表达可诱导巨噬细胞浸润和M2
极化;目标3。定义RORα对抑制乳腺癌形成和转移的影响。这
拟议的研究对其继承的科学重要性及其翻译潜力具有很高的影响。这项研究会
阐明组织极性破坏引起巨噬细胞的分子机制
浸润/分化。确定RORα在减少ROS产生和抑制NF-κB中的作用
激活可能会确定一种抑制乳腺癌发展和进展的新型策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ren Xu其他文献
Ren Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ren Xu', 18)}}的其他基金
Roles of mRNA Transfer in Cancer Cell-Platelet Communication
mRNA 转移在癌细胞-血小板通讯中的作用
- 批准号:
10748535 - 财政年份:2023
- 资助金额:
$ 22.68万 - 项目类别:
The PLOD2/succinate axis in cancer cell plasticity and stemness
PLOD2/琥珀酸轴在癌细胞可塑性和干细胞性中的作用
- 批准号:
10680932 - 财政年份:2023
- 资助金额:
$ 22.68万 - 项目类别:
Roles of Hsp47 in Breast Cancer Progression
Hsp47 在乳腺癌进展中的作用
- 批准号:
10529483 - 财政年份:2017
- 资助金额:
$ 22.68万 - 项目类别:
Roles of RORalpha in breast cancer development and progression
RORalpha 在乳腺癌发生和进展中的作用
- 批准号:
10199950 - 财政年份:2017
- 资助金额:
$ 22.68万 - 项目类别:
Roles of Hsp47 in Breast Cancer Progression
Hsp47 在乳腺癌进展中的作用
- 批准号:
10701814 - 财政年份:2017
- 资助金额:
$ 22.68万 - 项目类别:
相似国自然基金
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载自组装型非核苷类STING激动剂的亚精胺水凝胶用于抗肿瘤免疫治疗及机制研究
- 批准号:82303561
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向SIRT3小分子激动剂调控三阴性乳腺癌细胞自噬和免疫微环境的机制研究
- 批准号:82373193
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Transient Vanilloid Receptors and Vulvar Pain: New Therapeutic Targets for Vulvodynia
瞬时香草酸受体和外阴疼痛:外阴痛的新治疗靶点
- 批准号:
10582414 - 财政年份:2023
- 资助金额:
$ 22.68万 - 项目类别:
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
多功能纳米颗粒平台可预防酒精相关的 HCC 发展
- 批准号:
10736984 - 财政年份:2023
- 资助金额:
$ 22.68万 - 项目类别:
Applying human in vitro models to understand the link between trauma and tau pathology
应用人体体外模型来了解创伤与 tau 病理学之间的联系
- 批准号:
10786930 - 财政年份:2023
- 资助金额:
$ 22.68万 - 项目类别:
A novel breast cancer therapy based on secreted protein ligands from CD36+ fibroblasts
基于 CD36 成纤维细胞分泌蛋白配体的新型乳腺癌疗法
- 批准号:
10635290 - 财政年份:2023
- 资助金额:
$ 22.68万 - 项目类别:
Targeting Cholesterol Homeostasis to maintain vision in MS-like optic neuritis
针对多发性硬化症样视神经炎的胆固醇稳态以维持视力
- 批准号:
10657163 - 财政年份:2023
- 资助金额:
$ 22.68万 - 项目类别: